Antiproliferative Effects of Combined Tamoxifen and Gefitinib in Non-Small Cell Lung Cancer

被引：0
|
作者：
Hua Shen [1 ]
Yuan Yuan [1 ]
Wen Gao [1 ]
Jin Sun [1 ]
Shu, Yong-qian [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Canc Biotherapy Ctr, Nanjing 210029, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2009年 / 63卷 / 05期
关键词：
tamoxifen; gefitinib; NSCLC; EGFR/ER pathway;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
18
引用
收藏
页码：327 / 327
页数：1
相关论文
共 50 条
  • [31] Amphiregulin induces resistance to gefitinib in non-small cell lung cancer cell lines
    Busser, Benoit
    Lucie, Sancey
    Marie, Favrot
    Luc, Coll Jean
    Amandine, Hurbin
    [J]. BULLETIN DU CANCER, 2009, 96 : S55 - S55
  • [32] Management of patients with advanced non-small cell lung cancer: role of gefitinib
    Velcheti, Vamsidhar
    Morgensztern, Daniel
    Govindan, Ramaswamy
    [J]. BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 83 - 90
  • [33] Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer
    Hoshi, Manabu
    Takami, Masatsugu
    Ieguchi, Makoto
    Takaoka, Kunio
    [J]. EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2009, 19 (03): : 181 - 185
  • [34] Efficacy of the sequentially combined vinorelbine and gefitinib in Non-Small Cell Lung Cancer cell lines, an "in-vivo" study
    Bottoni, G.
    Dal Bello, M.
    Alama, A.
    Morbelli, S.
    Marini, C.
    Grossi, F.
    Sambuceti, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S264 - S264
  • [35] Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
    Ivette F Emery
    Chiara Battelli
    Paul L Auclair
    Kathleen Carrier
    Daniel M Hayes
    [J]. BMC Cancer, 9
  • [36] Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
    Galetti, Maricla
    Alfieri, Roberta R.
    Cavazzoni, Andrea
    La Monica, Silvia
    Bonelli, Mara
    Fumarola, Claudia
    Mozzoni, Paola
    De Palma, Giuseppe
    Andreoli, Roberta
    Mutti, Antonio
    Mor, Marco
    Tiseo, Marcello
    Ardizzoni, Andrea
    Petronini, Pier Giorgio
    [J]. BIOCHEMICAL PHARMACOLOGY, 2010, 80 (02) : 179 - 187
  • [37] Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
    Emery, Ivette F.
    Battelli, Chiara
    Auclair, Paul L.
    Carrier, Kathleen
    Hayes, Daniel M.
    [J]. BMC CANCER, 2009, 9 : 333
  • [38] Mechanisms of Gefitinib Plus Pemetrexed on Human Non-Small Cell Lung Cancer
    Lou, Y.
    Xu, J.
    Zhang, Y.
    Lu, J.
    Zhang, X.
    Wang, H.
    Zhang, W.
    Han, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S957 - S957
  • [39] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [40] Recurrence patterns of advanced non-small cell lung cancer treated with gefitinib
    Chen Min-jiang
    Zhong Wei
    Zhang Li
    Zhao Jing
    Li Long-yun
    Wang Meng-zhao
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (12) : 2235 - 2241
12345